Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Recursion Pharmaceuticals, Inc. - Class A Common Stock (NQ:RXRX)

5.680 -0.270 (-4.54%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 18,032,389
Open 5.620
Bid (Size) 5.610 (57)
Ask (Size) 5.660 (13)
Prev. Close 5.950
Today's Range 5.575 - 5.820
52wk Range 3.790 - 12.36
Shares Outstanding 168,425,907
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why Recursion Pharmaceuticals Stock Got Mashed on Monday
Investors weren't cheered by news from one of the biotech's rivals. 
Via The Motley Fool
The Median Retirement Savings for American Households Is $87,000. Here Are 3 Incredible Stocks to Buy Now and Hold for Decades.
You should probably be saving more, but even if you can't do that, you can get more out of the money you are able to save. 
Via The Motley Fool
Topics Artificial Intelligence Retirement

Performance

YTD
-21.2%
-21.2%
1 Month
+9.0%
+9.0%
3 Month
-0.4%
-0.4%
6 Month
-21.5%
-21.5%
1 Year
-22.6%
-22.6%

More News

Read More
Palantir, Nvidia & Tempus AI Could Be Pharma ETF Darlings That Don't Make Pills
Via Benzinga
Topics Artificial Intelligence ETFs
How Palantir, Tempus, Nvidia-Backed Recursion Are Disrupting Big Pharma
Via Benzinga
Recursion Acquires Full Rights to REV102, a Potential First-in-Class Oral ENPP1 Inhibitor for Hypophosphatasia
From Recursion Pharmaceuticals
Via GlobeNewswire
3 AI Stocks Partnered With Nvidia With Massive Growth Opportunities
Via The Motley Fool
Topics Artificial Intelligence
Biocomputers: The Future of Computing is Alive
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
Recursion Pharmaceuticals Sees Sharp Gain on AI Biotech Optimism
Via MarketMinute
Topics Artificial Intelligence
Recursion to Report Second Quarter 2025 Business Updates and Financial Results on August 5th
From Recursion Pharmaceuticals
Via GlobeNewswire
Top 2 Health Care Stocks You May Want To Dump This Quarter
Via Benzinga
History of Recursion Pharmaceuticals, Inc.: AI‑Driven Drug Discovery Beginnings (NASDAQ:RXRX)
Via MarketMinute
Topics Artificial Intelligence
Is Recursion Pharmaceuticals Gaining or Losing Market Support?
Via Benzinga
Why Is Recursion Pharma Stock Surging On Monday?
Via Benzinga
Galaxy Digital, Blaize Holdings, Verizon And Other Big Stocks Moving Higher On Monday
Via Benzinga
Jensen Huang's Nvidia Owns 6 Stocks. Here's the Best of the Bunch.
Via The Motley Fool
Topics Artificial Intelligence Initial Public Offering Intellectual Property
10 Under-the-Radar Tech Stocks With Incredible Growth Potential
Via The Motley Fool
Topics Artificial Intelligence
Here's Why Shares in Recursion Pharmaceuticals Surged Today
Via The Motley Fool
Microchip Technology, Tesla, Humacyte And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Why Is Microcap Rallybio Stock Trading Higher On Tuesday?
Via Benzinga
The Hottest 10 Artificial Intelligence (AI) Stocks on the Market
Via The Motley Fool
Topics Artificial Intelligence
Doctors Are Being Outpaced by AI-Powered Algorithms — Here’s What It Means for Investors
Via FinancialNewsMedia
Topics Artificial Intelligence Fraud
Alphabet-Backed Drug Discovery Firm Nears Human Trials Of AI-Developed Remedies, Says President: 'The Next Big Milestone Is...'
Via Benzinga
Topics Artificial Intelligence
What Analysts Are Saying About Recursion Pharmaceuticals Stock
Via Benzinga
Is the Market Bullish or Bearish on Recursion Pharmaceuticals?
Via Benzinga
Capital Flows Shift From Research Labs to Pharmacy Counters-A Watershed Moment for AI Health
Via FinancialNewsMedia
Topics Artificial Intelligence

Frequently Asked Questions

Is Recursion Pharmaceuticals, Inc. - Class A Common Stock publicly traded?
Yes, Recursion Pharmaceuticals, Inc. - Class A Common Stock is publicly traded.
What exchange does Recursion Pharmaceuticals, Inc. - Class A Common Stock trade on?
Recursion Pharmaceuticals, Inc. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Recursion Pharmaceuticals, Inc. - Class A Common Stock?
The ticker symbol for Recursion Pharmaceuticals, Inc. - Class A Common Stock is RXRX on the Nasdaq Stock Market
What is the current price of Recursion Pharmaceuticals, Inc. - Class A Common Stock?
The current price of Recursion Pharmaceuticals, Inc. - Class A Common Stock is 5.680
When was Recursion Pharmaceuticals, Inc. - Class A Common Stock last traded?
The last trade of Recursion Pharmaceuticals, Inc. - Class A Common Stock was at 08/01/25 04:00 PM ET
What is the market capitalization of Recursion Pharmaceuticals, Inc. - Class A Common Stock?
The market capitalization of Recursion Pharmaceuticals, Inc. - Class A Common Stock is 956.66M
How many shares of Recursion Pharmaceuticals, Inc. - Class A Common Stock are outstanding?
Recursion Pharmaceuticals, Inc. - Class A Common Stock has 957M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.